Technology | July 14, 2011

Cardiac Science to Include MTWA on All New Q-Stress Systems

July 14, 2011 – Cambridge Heart Inc., a developer of non-invasive diagnostic tests for cardiac disease, announced that it has reached an agreement with its original equipment manufacturing (OEM) partner, Cardiac Science Corporation, to include Cambridge Heart’s proprietary microvolt T-wave alternans (MTWA) module on every new Q-Stress system sale beginning July 11, 2011.  The company expects this initiative to significantly increase the placement of MTWA modules in coming quarters, which Cambridge Heart anticipates will provide the basis for future recurring revenue.

In order to maximize the commercial benefit of this initiative, Cambridge Heart and Cardiac Science have agreed to include the MTWA module in all new Q-Stress systems at no incremental cost through the end of 2011. 

Sudden cardiac arrest (SCA) is the leading cause of death in the United States, accounting for an estimated 300,000 deaths each year – more than lung cancer, breast cancer and HIV/AIDS combined. Out-of-hospital survival is less than 8 percent, making prediction and prevention critically important. It is estimated that there are approximately 10 to 12 million heart attack and heart failure patients who can benefit from annual MTWA testing. Microvolt T-wave alternans is a marker of SCA risk that is measured during a non-invasive treadmill test using Cambridge Heart’s proprietary technologies. The company’s MTWA test is the only one of its kind that is reimbursed by Medicare under a National Coverage Policy.

For more information: www.cambridgeheart.com

Related Content

HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG| August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
iRhythm and Stanford Researchers Develop Deep Learning-Based Cardiac Arrhthymia Detection Algorithm
News | Artificial Intelligence| July 11, 2017
iRhythm Technologies Inc. announced a collaboration with the Stanford Machine Learning Group that has resulted in the...
GE Healthcare, Rapiscan stress imaging agent, North America, Rapidscan Pharma Solutions Inc.
News | Pharmaceuticals| February 07, 2017
GE Healthcare’s Life Sciences business announced in January that it acquired Rapidscan Pharma Solutions Inc., which has...
stress echo, complex heart conditions, guideline document, ASE, EACVI
News | Stress Test Systems| February 03, 2017
For over 20 years, stress echocardiography (SE) has been widely used to help clinicians diagnose ischemic heart disease...
Sponsored Content | Videos | EP Mapping and Imaging Systems| February 01, 2017
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system.
medtronic cardioinsight electromapping system, electoanatomical mapping, noninvasive ep mapping

A screen shot of the waveforms and the the 3-D electo-mapping models created using the noninvasive CardioInsight system.

Technology | EP Mapping and Imaging Systems| February 01, 2017
February 1, 2017 — Medtronic received U.S.
Heart Test Laboratories, HTL, MyoVista ECG, common stock offering
News | ECG| January 31, 2017
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement...
Overlay Init